Skip to main content
Andrew Davis, MD, Ophthalmology, Edmonds, WA

Andrew P Davis MD

Cataract Related, Retinal Disease


Physician

Join to view full profile
  • 7315 212th St SWSte 200Edmonds, WA 98026

  • Phone+1 425-774-2020

  • Fax+1 425-454-7034

Join Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 5 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Andrew Davis, MD is a board certified ophthalmologist in Edmonds, Washington. He is currently licensed to practice medicine in Washington, New Jersey, and Pennsylvania.

Education & Training

  • Icahn School of Medicine at Mount Sinai/New York Eye and Ear Infirmary at Mount Sinai
    Icahn School of Medicine at Mount Sinai/New York Eye and Ear Infirmary at Mount SinaiResidency, Ophthalmology, 1987 - 1988
  • SUNY Downstate Health Sciences University
    SUNY Downstate Health Sciences UniversityResidency, Ophthalmology, 1984 - 1987
  • University of California (San Francisco)
    University of California (San Francisco)Internship, Internal Medicine, 1978 - 1979
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1978

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1992 - 2028
  • NJ State Medical License
    NJ State Medical License 1988 - 1993
  • HI State Medical License
    HI State Medical License 1979 - 1986
  • PA State Medical License
    PA State Medical License 1983 - 1986
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EMA, Modernizing Medicine, Inc., 2017
  • CMS Meaningful Use Stage 1 Certification EMA Mobile, Modernizing Medicine, Inc., 2017

Publications & Presentations

PubMed

Press Mentions

  • Guardant Health and Washington University to Present Study at 2024 ASCO Meeting Highlighting Utility of ctDNA to Address Racial Inequities in the Use of Targeted Therapies and Enrollment in Clinical Trials
    Guardant Health and Washington University to Present Study at 2024 ASCO Meeting Highlighting Utility of ctDNA to Address Racial Inequities in the Use of Targeted Therapies and Enrollment in Clinical TrialsJune 4th, 2024